Instent neointimal hyperplasia after percutaneous intervention for ST-elevation myocardial infarction and treatment with granulocyte-colony stimulating factor. Results from the stem cells in myocardial infarction (STEMMI) trial
Research output: Contribution to journal › Journal article › Research › peer-review
Recombinant granulocyte-colony stimulating factor (G-CSF) mobilized pluripotent cells from the bone marrow are proposed to have a regenerative potential. Though, a report of excessive instent restenosis, in patients treated with G-CSF before percutaneous coronary intervention (PCI) warrants caution.
| Original language | English |
|---|---|
| Journal | International Journal of Cardiology |
| Volume | 139 |
| Issue number | 3 |
| Pages (from-to) | 269-75 |
| Number of pages | 7 |
| ISSN | 0167-5273 |
| DOIs | |
| Publication status | Published - 18 Mar 2010 |
| Externally published | Yes |
- Aged, Angioplasty, Balloon, Coronary, Double-Blind Method, Female, Follow-Up Studies, Granulocyte Colony-Stimulating Factor, Hematopoietic Stem Cell Mobilization, Humans, Hyperplasia, Male, Mesenchymal Stromal Cells, Middle Aged, Myocardial Infarction, Neointima, Prospective Studies, Recombinant Proteins, Stents, Treatment Outcome
Research areas
ID: 47743733